Companies
Multi-plant target accounts across all verticals.
Abbott Laboratories
pharmaAbbott Laboratories, a diversified healthcare giant with 30+ US manufacturing locations, recently received FDA clearance for its next-generation Ultreon 3.0 AI-powered coronary imaging platform, demonstrating continued innovation in medical devices. The company maintains strong investor interest as a Dividend King with 54 consecutive years of dividend increases and a yield approaching 3%, though recent portfolio moves show some institutional reallocation away from the stock.
Amcor
packagingAmcor completed a major Berry acquisition that drove Q3 2026 net sales up 77% to $5.9B with $77M in synergies realized, while simultaneously investing $35M in a new advanced healthcare packaging coating facility in Malaysia. The company is also divesting non-core assets like beverage closure facilities to Closure Systems International while launching innovative sustainability-focused products.
Ball Corporation
packagingBall Corporation beat Q1 2026 earnings expectations with strong revenue and EPS growth, though margin compression from rising costs remains a headwind. The company maintains a diversified manufacturing footprint of 25+ facilities across the US while managing inflationary pressures and tariff impacts.
Baxter International
pharmaBaxter beat Q1 2026 earnings and revenue estimates despite margin contraction and lower year-over-year profits, driven by strong demand in medical devices and therapies. The company is focused on business stabilization and operational improvement across its diversified manufacturing footprint.
Becton Dickinson
pharmaBD is leveraging AI-powered medication management systems and launching breakthrough vascular access technology (CentroVena One™) to strengthen its market position in medical devices. The company maintains a robust North American manufacturing footprint with 20+ plants while facing near-term earnings pressure from China dynamics and research funding headwinds.
Berry Global
packagingBerry Global operates an extensive North American manufacturing footprint with 130+ facilities spanning 25+ states, establishing itself as a dominant player in plastic packaging solutions. With 40,000 employees and significant manufacturing concentration in high-density regions like California, Illinois, and the Southeast, the company maintains substantial operational scale.
Cardinal Health
pharmaCardinal Health raised its 2026 profit forecast for the second time this year, driven by strong demand for specialty drugs and pharma growth despite a revenue miss in Q3. The company beat EPS estimates significantly ($3.17 vs $2.8 consensus) and increased its quarterly dividend, signaling confidence in operational performance.
Cargill
foodCargill operates one of the largest private food and agriculture networks in the US with 150+ facilities spanning meat processing, grain handling, and distribution across 50+ locations. The company maintains significant manufacturing capacity concentrated in the Midwest and Great Plains regions with substantial distribution infrastructure along major logistics corridors.
Church & Dwight
personal-careChurch & Dwight delivered strong Q1 2026 results with 5% organic sales growth and margin expansion despite cost pressures from inflation and tariffs. The company exceeded revenue guidance and demonstrated continued market share gains across its global portfolio.
Clorox
personal-careClorox beat Q3 earnings estimates on cost-cutting measures despite flat sales, though gross margins came in below expectations due to supply chain costs and delayed savings. The company faces near-term headwinds from ERP transition and supply chain pressures, but the GOJO acquisition and international expansion are expected to drive long-term growth.
Colgate-Palmolive
personal-careColgate-Palmolive reported strong Q1 2026 results with 8.4% net sales growth driven by international demand and volume gains, particularly in Asia Pacific. The company maintains its Dividend King status and positive outlook despite margin pressures from costs and geopolitical headwinds.
Conagra Brands
foodConagra Brands is experiencing significant financial headwinds with stock down 40-65% over the past year amid margin pressure from consumer trade-downs and debt concerns. The company operates an extensive network of 50+ manufacturing plants across North America and released a fiscal 2025 sustainability report, but recent news focuses on dividend sustainability and valuation rather than operational growth.
Crown Holdings
packagingCrown Holdings reported strong Q1 2026 earnings beating estimates with $1.86 EPS, while maintaining its extensive 40+ plant network focused on metal can manufacturing for food and beverage. The company is returning capital to shareholders through dividends and maintaining operational momentum in its core packaging business.
Eli Lilly
pharmaEli Lilly is aggressively expanding US manufacturing capacity with $21B+ invested in Indiana since 2020, including a new dedicated genetic medicine facility in Lebanon. The company's blockbuster weight-loss drugs (Mounjaro, Zepbound) and tirzepatide pipeline are driving strong financial performance and bullish analyst sentiment.
Flowers Foods
foodFlowers Foods operates a massive 46-bakery network across the US with strong brands like Nature's Own and Dave's Killer Bread, but faces headwinds from GLP-1 drugs impacting demand and elevated debt from the Simple Mills acquisition. The company maintains a robust dividend yield (12.3%) despite market skepticism about leverage and sector challenges.
General Mills
foodGeneral Mills operates an extensive 30+ facility manufacturing footprint across the US while facing near-term headwinds from cost pressures and consumer weakness. The company is pursuing innovation and brand investment strategies to restore sales growth, though investor sentiment remains mixed on execution timing.
Graphic Packaging
packagingGraphic Packaging exceeded Q1 2026 earnings expectations and is executing cost reduction initiatives following a 90-day business review, while maintaining its extensive 25+ plant footprint across the US. The company is advancing sustainability goals through renewable energy agreements and reaffirming full-year guidance with expected adjusted cash flow of $700-800 million.
Hormel Foods
foodHormel Foods is executing a strategic portfolio optimization, divesting low-margin businesses like its whole-bird turkey operation while pivoting toward higher-margin branded proteins (SPAM, Skippy, Applegate). The company maintains a robust manufacturing footprint with 20+ production plants across the US and is recognized as a Dividend Aristocrat with attractive valuations, though recent stock performance has declined to 52-week lows.
KDC/One
personal-careKDC/One is a major personal-care manufacturer with an extensive network of 20+ manufacturing and distribution facilities across North America, headquartered in Longueuil, QC. The company operates significant production capacity across multiple regions with dual facilities in several key markets like New Jersey, Illinois, California, and Tennessee.
Kenvue
personal-careKenvue, the world's largest pure-play consumer health company, is in the final stages of a $48.7B acquisition by Kimberly-Clark, expected to close in H2 2026. The combined entity will operate under four geographic segments with established leadership, positioning it as one of the industry's largest players with a diverse portfolio including Tylenol, Listerine, Kleenex, and Huggies.
Kimberly-Clark
personal-careKimberly-Clark is executing strategic marketing campaigns (Natural Born Fighters for Huggies) and progressing a major $3.4B joint venture with Brazilian pulp giant Suzano that is nearing EU antitrust approval. The company maintains strong investor interest as a defensive consumer staples dividend stock with attractive valuations.
Kraft Heinz
foodKraft Heinz reported Q1 2026 earnings that beat estimates with steady progress on its turnaround strategy, including early momentum from 2025 investments in marketing and operations. The company maintains its 2026 outlook and continues dividend payments while implementing a plan to potentially split into two separate companies.
Newell Brands
personal-careNewell Brands reported Q1 2026 results beating analyst estimates on earnings and revenue despite posting a net loss, with all three segments delivering stronger-than-expected core sales. The company raised its full-year sales outlook, signaling confidence in its turnaround strategy driven by pricing gains, improved demand, and margin expansion despite softer volumes.
Pactiv Evergreen
packagingPactiv Evergreen is North America's largest food packaging manufacturer with an extensive domestic footprint of 60+ plants across the US. The company maintains a geographically distributed production network optimized for regional supply chain efficiency.
Pfizer
pharmaPfizer beat Q1 2026 earnings expectations with $14.5B in revenue, driven by strong performance from launched and acquired drugs, though adjusted EPS declined 18% year-over-year. The company faces a significant $17B patent cliff from key drug expirations like Eliquis and Vyndaqel, requiring successful pipeline launches and acquired product integration to sustain growth.
Post Holdings
foodPost Holdings operates a sprawling network of 50+ manufacturing and distribution facilities across North America, positioning itself as a major player in cereal, refrigerated foods, and food service. Recent analyst attention highlights potential earnings challenges ahead, though the company is benefiting from growing consumer demand for natural and clean-label food products.
Procter & Gamble
personal-careP&G is actively launching limited-edition product lines across its personal care brands (Native, Secret, Olay, Metamucil) with aggressive marketing campaigns targeting Gen-Z and wellness-conscious consumers. The company is leveraging cost discipline and supply-chain efficiency to maintain margins amid weak consumer volumes and inflationary pressures.
Sealed Air
packagingSealed Air is undergoing a major ownership transition as Clayton, Dubilier & Rice's $10.3B acquisition is moving toward completion in mid-2026 after receiving regulatory approvals in March 2026. The company operates 60+ global manufacturing facilities with strong US presence and recently reported Q4 earnings that beat estimates, though it will be delisting from NYSE as Diebold Nixdorf takes its S&P SmallCap 600 spot.
Silgan Holdings
packagingSilgan Holdings reported Q1 2026 earnings that beat analyst estimates with $0.78 EPS versus $0.74 consensus, though down from $0.82 year-ago, indicating steady but moderating performance. The company recently made an unsuccessful takeover bid for German medical packaging maker Gerresheimer, signaling strategic growth ambitions in the medical packaging segment.
Smithfield Foods
foodSmithfield Foods maintains its position as the world's largest pork processor with an extensive network of 40+ manufacturing and distribution facilities across the US. The company operates a highly integrated supply chain under Chinese parent company WH Group with significant capacity across the Midwest, Southeast, and coastal distribution hubs.
Sonoco Products
packagingSonoco is a diversified packaging manufacturer with 80+ US facilities experiencing near-term margin pressure from inflation and energy costs, though management maintains confidence in pricing power and productivity gains. The company maintains a strong 43-year dividend growth streak and is positioned as a defensive, income-generating play despite recent earnings headwinds.
TreeHouse Foods
foodTreeHouse Foods, the largest US manufacturer of private-label food and beverages with 40+ plants, is undergoing significant ownership transition following Investindustrial's completed acquisition at $22.50 per share in February 2026. The company maintains substantial institutional ownership and continues to attract investment analyst comparisons as a small-cap consumer staples player.
Tyson Foods
foodTyson Foods delivered strong Q2 2026 earnings with a beat on EPS ($0.87 vs $0.78 estimate) driven by robust chicken segment performance and pricing gains, while raising guidance on operating income and free cash flow. The company continues strengthening its balance sheet with $1 billion in debt reduction over the past year amid persistent headwinds in its beef business.
Unilever
personal-careUnilever posted strong Q1 2026 results with 3.8% underlying sales growth driven by emerging markets and power brands like Dove and Vaseline, while executing its largest portfolio overhaul including the McCormick Foods combination deal. The company is navigating shareholder criticism over Ben & Jerry's activism and financial transparency while launching a €1.5 billion share buyback.